A Glimpse Into the Adjacent Possible: Incorporating AI Into Medical Science
The implementation of emerging technologies requires front-line users to figure out what to do with the technology – how to adapt the technology to the... Read More
Your Edge In Biotech.
About David Shaywitz
David Shaywitz, MD PhD is a contributing writer for Timmerman Report.
Focus: the transformational opportunities and implementation challenges presented by emerging technologies in healthcare, biomedical discovery, and biopharmaceutical development, from NGS and cell therapies to digital biomarkers and the meaningful application of AI. Co-author (with Lisa Suennen): Tech Tonics: Can Passionate Entrepreneurs Heal Healthcare With Technology? (Hyperink Press, 2014).
Background: physician-scientist+management consultant, experience in drug development, strategic and commercial planning, tech+health.
Job: I am the founder of Astounding HealthTech, an advisory firm focused on the intersection of biopharma and health technology. Previously, I was Senior Partner, Takeda Ventures, Inc. (corporate/strategic VC focused on early-stage life science), and retain equity interest in DNAnexus from previous Chief Medical Officer role.
Other: I maintain a relationship with the Department of Biomedical Informatics, Harvard Medical School; I am also an Adjunct Scholar, American Enterprise Institute. Twitter: @DShaywitz (broadcast only; I do not engage on the platform). Views=my own, and may not represent the views of any organization with which I’m affiliated. For additional info, please see my personal website here.
Latest Contributions
Innovators Require An Exception-Oriented Mindset
Living in innovative domains like biomedical research requires an appreciation for the exceptional, the outlier. You might even argue that the goal of innovators –... Read More
Seeking Wellness Through More Data, Less Technology, and Better Habits
It only took a pandemic, but well-being has at last emphatically arrived in the corporate world. Before the pandemic, wellness was often viewed as just... Read More
Biopharmas: Digitizing, But Not Quite Digital
What a difference two years makes. In January 2020, I left my role as a senior partner at a corporate life-science venture fund to pursue... Read More
Peacetime vs Wartime CEO: A Useful Lens for Transformative Leaders?
As biotech execs cope with challenging market conditions (the XBI biotech index is off about 50% from its high of February 2021), I found myself... Read More
Beware of the Expert Fallacy, But Don’t Fall Into The Cynicism Trap
In December, a team led by two University of Pennsylvania scholars, psychologist Angela Duckworth (best known as author of Grit) and behavioral economist Katy Milkman... Read More
Improving Health and Wellness in 2022
As we start to think about 2022 and improving our health and wellness in the New Year, we make ambitious resolutions and urgently try to... Read More
Corporate Health and Wellness Has New Urgency And Vision
Like no other event in our collective experience, the pandemic reminded us of the need for an integrative view of wellbeing beyond traditional measures of... Read More